Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
about
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitisMetabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential linkDietary choline requirements of women: effects of estrogen and genetic variationMethionine deficiency and hepatic injury in a dietary steatohepatitis modelRedox mechanisms in hepatic chronic wound healing and fibrogenesisHypertriglyceridemia: its etiology, effects and treatmentNutrition and Physical Activity in Nonalcoholic Fatty Liver DiseaseThe Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver DiseaseThe role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic reviewReview of nonalcoholic fatty liver disease in women with polycystic ovary syndromeNovel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and developmentNon-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentNonmedicinal interventions in nonalcoholic fatty liver diseaseDiagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of EndocrinologyBile acid metabolism and signalingObesity and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese populationCross-talk between the thyroid and liver: a new target for nonalcoholic fatty liver disease treatmentRole of innate immunity in the development of hepatocellular carcinomaModulation of glucose metabolism by the renin-angiotensin-aldosterone systemEfficacy of Berberine in Patients with Non-Alcoholic Fatty Liver DiseaseProstatic inflammation induces fibrosis in a mouse model of chronic bacterial infectionHepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosisFenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosisEmerging role of microRNAs in liver diseasesWeight control and prevention of metabolic syndrome by green tea.Vitamin E and nonalcoholic fatty liver diseasePhysiological and Pathogenic Roles of Prolyl Isomerase Pin1 in Metabolic Regulations via Multiple Signal Transduction Pathway ModulationsTransient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decadesBile acid signaling in metabolic disease and drug therapyFarnesoid X receptor: from medicinal chemistry to clinical applicationsPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesRole of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic SteatohepatitisSustained proliferation in cancer: Mechanisms and novel therapeutic targetsBiochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in miceDifference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in miceEffect of diet on expression of genes involved in lipid metabolism, oxidative stress, and inflammation in mouse liver-insights into mechanisms of hepatic steatosisSusceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver DiseaseRole of β-adrenergic receptors in regulation of hepatic fat accumulation during agingActivation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease
P2860
Q24243125-092A5D22-772C-49E0-B223-1E37211D6523Q24631619-7EDA2420-F9DF-4259-AD2C-25793EC98E73Q24632118-B4365690-9718-4066-BEE9-3316C4261382Q24650636-7DCE824C-6E80-43E6-834A-F04A07CB7674Q24656684-23D4536A-06B4-4665-B51C-E8E95E9B4E2EQ24672914-0B82287F-3D7B-4B76-A6C7-4050D9216E14Q26771752-9ECA1623-2950-44A3-A7EF-4FB25FAB4110Q26780509-ED8C21BD-96DF-4B70-B82F-FA75473B73C7Q26825269-0B4899C9-73A3-4E14-BC60-9B68DA781415Q26828765-60080A09-7CA6-4FF4-927C-CC57025CB6DAQ26851211-015611F3-B465-472A-B18E-BFFF4E7F5773Q26852019-CE56EAC9-0E34-41D6-9C10-FD2F0D48FC13Q26992054-3D2433C5-74B5-4972-82C3-B64646982E2FQ26998471-9D54CFA1-3948-495C-84BD-6A320CE0290AQ27002873-9928B7EA-93BC-4802-94C9-7186D1E2F798Q27003363-8BA44552-5660-458F-881E-85D83B0E20A1Q27011338-0D6EFD4C-AB27-4F6C-9230-5BDD42A375A6Q27024780-E90D29BD-9479-4290-92DC-1B17B3FAC406Q27026157-0D79A15F-4C78-4F60-8213-736552814DF4Q27301440-7EE3F71F-F8AE-40CF-94FE-2B39BC5BCE5CQ27321863-C602507E-14AB-4895-93FF-681757BF4DD8Q27488919-41BC4DD4-81FA-4BC5-ACCD-D44275C1E2DBQ27489896-F721F622-785C-41D9-A800-25A5FF5D9F9FQ27490492-42B4DFDC-0779-4494-85DA-6E65FD3AA8DDQ27687558-4D7720C5-9F73-4027-82D2-3E285B09863DQ27693883-A98BE83A-AC68-40C2-8DF0-3E00D766ACC0Q28079712-E0BFE20C-6376-48DB-A30A-64D385F2ED4BQ28084154-55E63547-84D6-4819-B28F-88D5C56E458AQ28088798-385DF259-B6C7-43EF-AD5B-48DF201E7271Q28244875-349A6CA0-04E6-4732-99F9-1A42A60A20CCQ28266284-9883DF91-3A13-4371-A72A-0DE97297DD3EQ28272678-5F66848F-0302-49C3-B628-222286DC369BQ28354735-117CBDA6-3FCD-47CE-BB0F-A5382F632FE3Q28396388-0295C67B-55B2-4185-8344-C60D0472A941Q28468601-A880D9A7-78E8-4813-A909-5AF30A62CA04Q28507402-0569E7BD-212C-4124-A62E-43B6AAA78EE7Q28539815-72A627C5-CA7E-4C36-8BD9-75700D1184CAQ28551941-E100F535-0304-440B-BB72-B5A99578DE2DQ28572834-D08B431C-2D92-4179-89A9-5C8883677F95Q28576904-0FD485ED-AA68-4DF0-80C1-94A96F8817B2
P2860
Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
@ast
Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
@en
type
label
Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
@ast
Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
@en
prefLabel
Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
@ast
Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
@en
P356
P1433
P1476
Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
@en
P2093
Claire Z Larter
Geoffrey C Farrell
P304
P356
10.1002/HEP.20973
P407
P433
P577
2006-02-01T00:00:00Z